2 ms·
> Astronomically high R&D costs, most of which is the cost of obtaining regulatory approval. And yet, IIRC, pharmaceutical companies spend about 20% of their r
by js8 10y ago
> Astronomically high R&D costs, most of which is the cost of obtaining regulatory approval.
And yet, IIRC, pharmaceutical companies spend about 20% of their revenues on research, but about 40% or more on marketing. These costs are galaxonomical!
- aantix 10y agoThe average number of emails you must send before a subscriber starts to consider you safe to buy from.. Eight. Assuming one's health has an even higher threshold, and that a pharma company can't exactly cold email everyone in the U.S, well... That's a lot of commercials to get the word out. That's 800,000+ doctors to educate on a new option.. Marketing always goes hand in hand with product development. I'd rather have a pharma company that's still in business charging $30,000/mo for a solution vs a company that charged the minimum, and thus has thrown away any chances of making successful products in the future.